'Healthy menopause': The European Menopause and Andropause Society (EMAS) 2026 framework for precision, digital, and...

On average, women now spend more than one-third of their lives in the post-reproductive period, yet menopause care across Europe remains fragmented and uneven. Since the first publication of its model of care by the European Menopause and Andropause Society (EMAS) in 2016, major advances in precision medicine, digital phenotyping, biomarkers derived from data collected by wearable devices, artificial intelligence, hybrid care delivery, and workplace health have reshaped clinical opportunities and societal expectations. At the same time, population aging, rising multimorbidity, and increasing public and employer awareness position menopause as a public health inflection point rather than a narrow reproductive transition.

This updated EMAS Position Statement, 'Healthy Menopause', sets out a future-oriented framework for the coming decade.

This Position Statement was developed through iterative consultation and consensus among the authors, informed by current evidence, existing clinical guidance, and relevant regulatory frameworks.

The framework integrates risk stratification, validated digital tools, and clinical decision support. It also structures menopause healthcare considerations into a scalable tiered care architecture comprising digital access, trained menopause healthcare professionals, multidisciplinary specialist centers, and a supportive policy and governance environment. It provides actionable recommendations for clinicians, health systems, professional societies, employers, and researchers, including on competency-based training and accreditation, quality standards, governance requirements for digital health and artificial intelligence, and mechanisms to monitor outcomes and equity. By linking clinical innovation, digital ecosystems, and societal determinants, this Position Statement outlines a blueprint for equitable, preventive, and personalized menopause care across Europe.